GLPwatch
Trials (2167)
Page 9 of 37.
- Effect of Exenatide on Cortisol Secretion
- The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
- Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
- GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
- Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
- A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
- A Trial to Determine the Efficacy and Safety of Presendin in IIH
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
- Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
- Safety Evaluation of Adverse Reactions in Diabetes
- A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
- WEgovy Real World Assessment of Weight Loss in Korea
- Safety and Tolerability of NN9068 in Healthy Male Volunteers
- Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
- Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
- A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
- Probiotic Intervention on Body Weight
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
- 3mg Liraglutide for Overweight or Obesity
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
- Tirzepatide for Treatment of CCCA
- A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
- Safety and Efficacy of Exenatide as Monotherapy
- Visualizing Beta Cells in Patients With a History of Gestational Diabetes
- Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer
- Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
- A Study of HS-20094 in Patients With T2DM
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
- People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
- Impact of Exenatide on Sleep Duration
- Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
- Metabolism and Excretion of Liraglutide in Healthy Male Volunteers
- Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
- Liraglutide and Peripheral Artery Disease
- The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
- Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
- Life Style Modification Medical and Surgical Management in Patients With Obesity
- Metabolic Surgery for Atrial Fibrillation Elimination
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
- A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
- Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
- WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
- Preoperative Weight Loss for Open Abdominal Wall Reconstruction
- A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
- A Study of LY3493269 in Participants With Type 2 Diabetes